Medicines, Poisons and Therapeutic Goods Regulation 2026
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Medicines, Poisons and Therapeutic Goods Regulation 2026
Start here
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
24 Obtaining wholesale supply by research institutions, universities and laboratories
(1) This section applies to the following—
(a) a Schedule 2, 3, 4 or 7J“a” substance, other than a Schedule 4D substance,
(b) a prohibited scheduled substance or prohibited drug, if the substance or drug is an in-vitro diagnostic and analytical preparation containing less than 0.001% of the substance or drug.
(2) For the Act, Part 2.3, obtaining wholesale supply of a substance or drug to which this section applies by the following is authorised, but only if wholesale supply is for a relevant purpose—
(a) a person in charge of a laboratory of a university,
(b) a person in charge of a laboratory or department at a research institution that is a member of the Association of Australian Medical Research Institutes,
(c) a person in charge of a laboratory or department of NSW Health Pathology,
(d) a person in charge of an analytical laboratory accredited by the National Association of Testing Authorities,
(e) a person acting under the direction of a person specified in paragraph (a)–(d).